Yongjiang Li

机构：Dalian University of Technology, Dalian University, Dalian Municipal Central Hospital · ORCID：0000-0001-6882-7862

发表论文 187 篇 · 总被引 6892 次 · h-index 46

代表论文

• Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment (2024 · Nature Nanotechnology · 被引 167)
• Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment (2024 · Advanced Materials · 被引 69)
• Innate immunity-modulating nanobiomaterials for controlling inflammation resolution (2024 · Matter · 被引 34)
• Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms (2024 · Frontiers in Endocrinology · 被引 34)
• Synthetic carbon-based lanthanide upconversion nanoparticles for enhanced photothermal therapy (2025 · Nature Communications · 被引 32)
• Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease (2025 · Science Translational Medicine · 被引 30)